JD Health's stock price rose more than 4.5%.

JD Health's stock rises more than 4.5%. In terms of news, JD Health recently released its mid-term performance for 2025, showing a 24.5% year-on-year increase in revenue to 35.29 billion yuan in the first half of the year, a 27.45% year-on-year increase in net profit to 2.6 billion yuan, and a user base exceeding 200 million annual active users.